. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab 285: E123-E129, 2003; 10.1152/ajpendo.00021.2003.-We examined the effects of inhibiting nitric oxide synthase with N -nitro-L-arginine-methyl ester (L-NAME) on total hindlimb blood flow, muscle microvascular recruitment, and hindlimb glucose uptake during euglycemic hyperinsulinemia in vivo in the rat. We used two independent methods to measure microvascular perfusion. In one group of animals, microvascular recruitment was measured using the metabolism of exogenously infused 1-methylxanthine (1-MX), and in a second group contrast-enhanced ultrasound (CEU) was used. Limb glucose uptake was measured by arterial-venous concentration differences after 2 h of insulin infusion. Saline alone did not alter femoral artery flow, glucose uptake, or 1-MX metabolism. Insulin (10 mU ⅐ min Ϫ1 ⅐ kg Ϫ1 ) significantly increased hindlimb total blood flow (0.69 Ϯ 0.02 to 1.22 Ϯ 0.11 ml/min, P Ͻ 0.05), glucose uptake (0.27 Ϯ 0.05 to 0.95 Ϯ 0.08 mol/min, P Ͻ 0.05), 1-MX uptake (5.0 Ϯ 0.5 to 8.5 Ϯ 1.0 nmol/min, P Ͻ 0.05), and skeletal muscle microvascular volume measured by CEU (10.0 Ϯ 1.6 to 15.0 Ϯ 1.2 video intensity units, P Ͻ 0.05). Addition of L-NAME to insulin completely blocked the effect of insulin on both total limb flow and microvascular recruitment (measured using either 1-MX or CEU) and blunted glucose uptake by 40% (P Ͻ 0.05). We conclude that insulin specifically recruits flow to the microvasculture in skeletal muscle via a nitric oxide-dependent pathway and that this may be important to insulin's overall action to regulate glucose disposal. capillary recruitment; nitric oxide; nitric oxide synthase; muscle blood flow THERE IS ABUNDANT EVIDENCE that insulin augments total limb blood flow in humans (2, 29, 33) and experimental animals (20, 22) in a time-and dose-dependent fashion. It has been suggested that this action of insulin could, by facilitating the delivery of glucose and itself to muscle, contribute to insulin's overall action on glucose disposal (3), although this remains controversial (33).Substantial evidence suggests that nitric oxide (NO) is involved in insulin's action to increase limb blood flow in humans (5,8,25,26,29). NO in muscle is produced by nitric oxide synthase (NOS), located in both vascular endothelium (28) and myocytes (16). Inhibition of NO production by N -mono-methyl-L-arginine (L-NMMA) can fully abolish the effect of insulin to increase limb total blood flow in humans (4,5,26,29). In one study, this agent partially blocked (ϳ25%) insulin-mediated glucose uptake as well (5). Baron et al. (6) have also reported that, in the rat, L-NMMA increases mean arterial pressure and reduces whole body glucose infusion rate in a dose-dependent fashion during a euglycemic insulin clamp (12 mU⅐min Ϫ1 ⅐kg
Ϫ1). Using intravital microscopy, Chen and Messina (8) demonstrated that insulin induces vasodilation of firstorder arterioles in rat cremaster and that the addition...